Patents by Inventor Anthony Carpanzano

Anthony Carpanzano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230201124
    Abstract: Solid dosage forms, tablet processing aids, and methods of preparing solid dosage forms and tablet processing aids are described. The solid dosage forms contain a lubricant contains a rice bran wax. The amount of the rice bran wax in the lubricant is from about 60% to about 100% (w/w).
    Type: Application
    Filed: December 27, 2022
    Publication date: June 29, 2023
    Applicant: JRS Pharma GmbH & Co. KG
    Inventors: Kenneth L. Seufert, Anthony Carpanzano, Theodore Montalto
  • Patent number: 10166185
    Abstract: The present invention is directed to an excipient which can be used to manufacture tablets containing oily active ingredients such as oily drugs, and pharmaceutical compositions containing the same.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: January 1, 2019
    Assignee: J. Rettenmaier & Söhne GmbH + Co KG
    Inventors: Anthony Carpanzano, Michael Nagel
  • Publication number: 20160361261
    Abstract: The present invention is directed to an excipient which can be used to manufacture tablets containing oily active ingredients such as oily drugs, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 15, 2016
    Applicant: J. Rettenmaier & Söhne GmbH + Co KG
    Inventors: Anthony Carpanzano, Michael Nagel
  • Publication number: 20150037424
    Abstract: Provided is a sustained release oral solid preparation comprising aripiprazole or a salt thereof as an active ingredient described below, and a method for producing the sustained release oral solid preparation.
    Type: Application
    Filed: March 6, 2013
    Publication date: February 5, 2015
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Robert A. Forbes, Suresh Mallikaarjun, Arash Raoufinia, Ron Casey, Junichi Jinno, Hiroyuki Nagao, Donald Diehl, Erik Pecorelli, Anthony Carpanzano
  • Publication number: 20070048376
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 1, 2007
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Anand Baichwal, Philip Goliber, Anthony Carpanzano, Thomas Sciascia, Donald Diehl, Brian Vogler
  • Publication number: 20050063909
    Abstract: The present invention provides an oral dosage form comprising a first composition and a second composition. The first composition comprises an effective amount of a therapeutic agent and the second composition comprises an effective amount of an adverse-effect agent. The adverse-effect agent is covered with a coating that is substantially insoluble in the gastrointestinal tract. In one embodiment, the adverse-effect agent is coated with an outer base-soluble layer and an inner acid-soluble layer. The therapeutic agent can be uncoated or can be coated with a coating having an outer acid-soluble layer and an inner base-soluble layer. The dosage form discourages administration of the therapeutic agent by other than oral administration.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 24, 2005
    Inventors: Curtis Wright, Anthony Carpanzano